Nabriva Therapeutics plc Stock Split Ratio
Nabriva Therapeutics plc reported Stock Split Ratio of 100.00% for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2021-03-11
- Nabriva Therapeutics plc stockholders' equity note, stock split, conversion ratio for fiscal 2020 was 100.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|
| 2020-12-31 | 100.00% 10-K · filed 2021-03-11 |